GO BACK

NEWGEN: New generation biomimetic and customized implants for bone engineering

Objective

This COST Action, NEWGEN, aims at creating the seed for the European research and industry collaboration, combining basic knowledge from academic laboratories, R&D centres, medical units from hospitals, and a significant number of companies.

Start Date:
October 2, 2013
End Date:
October 1, 2017
Funded by:

COST Action MP1301 Materials, Physical And Nanosciences. COST is supported by the EU RTD Framework Programme.

Consortium Partners

FLUIDINOVA, S.A. among more than 70 partners from 21 countries.

Read More